AN

Aspi Navroze Raimalwala

Active Director Director DIN 02454860
DIN 02454860 First appointment Sep 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2015
Shareholding value •••• Premium profile

About Aspi Navroze Raimalwala

Data last updated:

Aspi Navroze Raimalwala is a Director at Fredun Pharmaceuticals Ltd (since 2015). The company operates in Pharma. Fredun Pharmaceuticals Ltd reported revenue of ₹639 Cr (FY 2026).

DIN 02454860
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2015
Oldest Company Age 39 yrs
Largest company Fredun Pharmaceuticals Ltd · ₹639 Cr (FY 2026)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fredun Pharmaceuticals Ltd L24239MH1987PLC043662
Director30 Sep 20151987₹639 Cr (FY 2026)Active

Board colleagues of Aspi Navroze Raimalwala

Directorship timeline

Open interactive timeline →
Fredun Pharmaceuticals Ltd
Premium access

Shareholding and investment profile for Aspi Navroze Raimalwala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aspi Navroze Raimalwala

Aspi Navroze Raimalwala currently holds 1 directorship: Fredun Pharmaceuticals Ltd (Director, since 30 Sep 2015, revenue ₹639 Cr (FY 2026)).

Aspi Navroze Raimalwala was first appointed on 30 Sep 2015 as Director at Fredun Pharmaceuticals Ltd.

The current boards of Aspi Navroze Raimalwala's companies include Anshu Gyan Agarwal (Fredun Pharmaceuticals Ltd), Daisy Cyril Dsouza (Fredun Pharmaceuticals Ltd), Daulat Nariman Medhora (Fredun Pharmaceuticals Ltd), Fredun Nariman Medhora (Fredun Pharmaceuticals Ltd), Fredun Nariman Medhora (Fredun Pharmaceuticals Ltd), Pooja Narendra Sanghavi (Fredun Pharmaceuticals Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available